CSF3 and synovial sarcoma: Some new approaches to treatment have emerged, such as granulocyte and monocyte adsorption apheresis for patients with recurrent SS, drug-induced SS by Filgrastim or patients with high levels of G-CSF [72], or Adalimumab treatment in patients with recurrent subcutaneous SS [73].